Skip to Main Content

Paper Details

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.
Nat Commun
12
2021
AR, CRPC, ERBB2, KLF5, advanced prostate cancer, androgen, androgen receptor, basal epithelial cell, basal epithelial cell phenotypes, castration-resistant prostate cancer, chromatin, oncogene, prostate cancer, prostate cancers, stem cell transcription factor Krppel-like factor 5
Author NameAffiliation
Loredana Puca
Yanyun ZhuOncode Institute, The Netherlands Cancer Institute
Andries M BergmanOncode Institute, The Netherlands Cancer Institute
Tesa M SeversonOncode Institute, The Netherlands Cancer Institute
Luke A SelthFlinders Health and Medical Research Institute and Flinders Centre for Innovation in Cancer, Flinders University
Luke A SelthDame Roma Mitchell Cancer Research Laboratories and Freemasons Foundation Centre for Men's Health, Adelaide Medical School, The University of Adelaide
Amina ZoubeidiUniversity of British Columbia
Amina Zoubeidi
Martin E GleaveUniversity of British Columbia
Martin E Gleave
Rohan BarejaEnglander Institute for Precision Medicine
Andrea SbonerEnglander Institute for Precision Medicine
Andrea SbonerEnglander Institute for Precision Medicine
Jason S CarrollUniversity of Cambridge
Wilbert ZwartOncode Institute, The Netherlands Cancer Institute
Himisha BeltranDana Farber Cancer Institute and Harvard Medical School
Himisha BeltranDana Farber Cancer Institute and Harvard Medical School
  • 1 - 17

Datasets

Release 1.2